We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter Exhibits New Lab Solutions in Dubai

By LabMedica International staff writers
Posted on 08 Feb 2017
Print article
Image: The DxN molecular diagnostics system (Photo courtesy of Beckman Coulter).
Image: The DxN molecular diagnostics system (Photo courtesy of Beckman Coulter).
Beckman Coulter, Inc., an international leader in developing clinical diagnostic products and solutions, exhibited its laboratory solutions, including its DxN VERIS molecular diagnostics system and DxH 500 hematology system, at MEDLAB 2017.

The company’s DxN VERIS molecular diagnostics system aims to revolutionize laboratory workflow by delivering greater productivity and increased flexibility to laboratories, ensuring that results are available to physicians as quickly as possible, for faster clinical decision-making and positively impacting the patient pathway.

Beckman Coulter’s DxH 500 hematology system is the first of a new series of advanced hematology analyzers specifically designed for laboratories with low-volume hematology workloads. With its small sample volume requirements, intuitive software and low reagent consumption, the advanced 5-part differential system aims to simplify the workload in a low-volume lab.

Also on display at the 4-day event held from February 6-9, 2017, in Dubai, UAE, was Beckman Coulter’s DxH Connected Workcells solution for in vitro diagnostic use. In addition to reducing manual work with accurate first-pass results and processing specimens faster with customizable workflow solutions for labs, it delivers reliable results from difficult specimens and also simplifies autovalidation with comprehensive data management.


Print article

Channels

Molecular Diagnostics

view channel
Image: Histopathology of neurofibrillary tangles in the brain of a patient with Alzheimer`s disease (Bielschowski silver stain) (Photo courtesy of Dimitri P. Agamanolis, MD).

Alzheimer's Disease Subtypes Proposed from Brain Gene Expression Profiles

Alzheimer’s disease (AD) is the most common form of dementia in the elderly, estimated to affect more than 5.8 million individuals in the USA and more than 50 million worldwide, with almost half of individuals... Read more

Industry

view channel
Illustration

Thermo Fisher Acquires Point-of-Care Molecular Diagnostics Provider Mesa Biotech

Thermo Fisher Scientific Inc. (Waltham, MA, USA) has entered into a definitive agreement to acquire Mesa Biotech (San Diego, CA, USA), a privately held molecular diagnostic company, for approximately USD... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.